NFKB1 and breast cancer: Altogether, our data provide evidence that YM155 is an effective cell death inducer in breast cancer cells, even in presence of their microenvironment and that both homeostatic pathways NF-kB and autophagy control the signaling pathway leading to cell death in YM155-treated cells.